cannabis indica

Delta-8-THC

O que é Delta-8-THC

O delta-8-THC é um isômero do delta-9-THC: mesma fórmula molecular, com a dupla ligação em posição diferente. É psicoativo, com potência estimada menor que a do delta-9.

O que o torna um caso à parte é a origem. Na planta, o delta-8 aparece em traços — quantidades pequenas demais para extração viável. Praticamente todo o delta-8 disponível comercialmente é produzido em laboratório por conversão química do CBD, o que levanta questões de pureza e de subprodutos de reação que a literatura vem examinando.

Essa rota de produção também explica por que o composto ganhou relevância regulatória: partindo de CBD de cânhamo, ele ocupou uma zona cinzenta em várias jurisdições. Os estudos deste acervo tratam tanto da farmacologia quanto dessa dimensão de segurança e controle de qualidade.

No acervo

O acervo do Cannabis Indica reúne 76 estudos científicos que tocam o composto Delta-8-THC, publicados entre 1942 e 2024. Pela leitura automatizada, 33 (43%) foram classificados como favoráveis, 34 (45%) como inconclusivos e 9 (12%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (29 estudos), seguido de estudo laboratorial (19). As condições mais associadas são Dor, Câncer e Inflamação.

Estudos indexados
76
Período coberto
1942–2024
Favoráveis
33 · 43%
Inconclusivos
34 · 45%
Desfavoráveis
9 · 12%
Termo original
Delta-8-THC

O acervo em números

Tipo de estudo

Metanálise29
Estudo Laboratorial19
Estudo em Animais17
Ensaio Clínico6
Ensaio Clínico Duplo-Cego3
Metanálise Clínica2

Direção do resultado

Favorável33
Inconclusivo34
Desfavorável9

Por década

1940s1
1970s4
1980s5
1990s6
2000s10
2010s4
2020s46

76 estudos

Filtrar e buscar no acervo →
  1. 2024

    Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

    InconclusivoMetanáliseDorDor — AgudaAnandamida (AEA)Tetraidrocanabinol (THC)+7
  2. 2024

    Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice

    FavorávelMetanáliseAnandamida (AEA)Tetraidrocanabinol (THC)+9
  3. 2023

    CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation

  4. 2023

    Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC-MS-MS analysis in urine

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)
  5. 2023

    Delta-8-THC association with psychosis: A case report with literature review

  6. 2023

    The Cross Reactivity of Cannabinoid Analogs (Delta-8-THC, Delta-10-THC and CBD), their metabolites, and Chiral Carboxy HHC metabolites in Urine of Six Commercially Available Homogeneous Immunoassays

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Ácido Canabidiólico (CBD-a)
  7. 2022

    Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): Results from urine drug testing in Sweden

    InconclusivoMetanálise
  8. 2022

    Cannabinoids as anticancer drugs: current status of preclinical research

  9. 2022

    Cannabinoids: Therapeutic Use in Clinical Practice

  10. 2022

    Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein

  11. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  12. 2022

    Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology

  13. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+28
  14. 2022

    Delta-8-THC: Delta-9-THC’s nicer younger sibling?

    FavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica
  15. 2022

    Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study

    DesfavorávelMetanáliseCâncer — MamaCâncer — PulmãoCâncer — Cólon+17
  16. 2022

    In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+14
  17. 2022

    Industrial Hemp ( Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+3
  18. 2022

    Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+3
  19. 2022

    Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies

  20. 2022

    Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells

    FavorávelEstudo LaboratorialCâncerInflamaçãoEstresse OxidativoTetraidrocanabinol (THC)+1
  21. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  22. 2022

    Popularity of Delta-8 THC on the Internet Across US States, 2021

    FavorávelMetanálise
  23. 2022

    Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review

    InconclusivoMetanáliseCanabigerol (CBG)Canabinol (CBN)+2
  24. 2022

    Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial Cannabis (Cannabis sativa L.) Cultivars

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+8
  25. 2022

    Public interest in ∆ 8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆ 9-Tetrahydrocannabinol (delta-9-THC) use

    InconclusivoMetanálise
  26. 2022

    Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC

    InconclusivoMetanáliseTetraidrocanabinol (THC)
  27. 2022

    Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+1
  28. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

  29. 2022

    Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution

    InconclusivoMetanáliseEfeitos Adversos da CannabisPsicose
  30. 2022

    Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users

    InconclusivoEnsaio Clínico Duplo-CegoCanabinol (CBN)Tetraidrocanabivarina (THCV)
  31. 2021

    Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report

  32. 2021

    Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use

  33. 2021

    Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+17
  34. 2021

    Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  35. 2021

    Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study

    FavorávelEnsaio ClínicoCanabigerol (CBG)Canabinol (CBN)+7
  36. 2021

    Development and Optimization of Supercritical Fluid Extraction Setup Leading to Quantification of 11 Cannabinoids Derived from Medicinal Cannabis

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+7
  37. 2021

    Effects of tetrahydrocannabinols on human oral cancer cell proliferation, apoptosis, autophagy, oxidative stress, and DNA damage

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — Boca
  38. 2021

    Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence

  39. 2021

    Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids

  40. 2021

    Novel Δ8‐Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals

  41. 2021

    Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabinol (CBN)+3
  42. 2021

    Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

  43. 2021

    Δ8-THC: Legal Status, Widespread Availability, and Safety Concerns

    DesfavorávelMetanáliseEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  44. 2020

    Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

    FavorávelEstudo em AnimaisDorDor — OcularUveíteCanabinoides Sintéticos AM-x
  45. 2020

    Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy

  46. 2020

    The Influence of Hemp Extract in Combination with Ginger on the Metabolic Activity of Metastatic Cells and Microorganisms

  47. 2018

    Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation

  48. 2018

    The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.

  49. 2017

    Molecular Targets of the Phytocannabinoids-A Complex Picture

    InconclusivoMetanáliseTetraidrocanabinol (THC)Canabigerol (CBG)+3
  50. 2016

    Cannabis - the Israeli perspective

  51. 2008

    The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

    InconclusivoMetanáliseCanabigerol (CBG)Tetraidrocanabivarina (THCV)
  52. 2007

    Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew

  53. 2006

    Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls

    InconclusivoEnsaio ClínicoAnsiedadeDepressãoDisfunção Cognitiva
  54. 2004

    Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors

    FavorávelEstudo LaboratorialTetraidrocanabinol (THC)Canabinoides Sintéticos WIN-x+3
  55. 2004

    Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol

    FavorávelEstudo LaboratorialDoenças de PeleCanabinol (CBN)
  56. 2004

    In vitro/in vivo correlation studies for transdermal delta 8-THC development

    InconclusivoEstudo Laboratorial
  57. 2004

    Synthesis and antitumor activity of quinonoid derivatives of cannabinoids

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCanabinol (CBN)
  58. 2004

    Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome Metabólica
  59. 2003

    Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain: A Randomized Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaDor — Neuropatia Periférica
  60. 2003

    Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols

    InconclusivoEstudo em Animais
  61. 1999

    Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study

    InconclusivoEnsaio ClínicoGastroparesia
  62. 1995

    An efficient new cannabinoid antiemetic in pediatric oncology.

    FavorávelEnsaio ClínicoNáusea e VômitoNáusea e Vômito por Quimioterapia
  63. 1994

    Suppression of experimetal autoimmune encephalomyelitis by cannabinoids Author links open overlay panel

    FavorávelEstudo em AnimaisEncefalite e Mielite
  64. 1993

    Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC

    InconclusivoEstudo em AnimaisCanabinoides Sintéticos CP-x
  65. 1991

    Pharmacological evaluation of halogenated delta 8-THC analogs

    InconclusivoEstudo em Animais
  66. 1991

    Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol

    FavorávelEstudo em AnimaisTetraidrocanabinol (THC)
  67. 1988

    Perinatal exposure to cannabinoids alters neurochemical development in rat brain

    InconclusivoEstudo em AnimaisGestação
  68. 1986

    Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects

    DesfavorávelEnsaio Clínico Duplo-CegoInfertilidade Masculina
  69. 1986

    Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice

    InconclusivoEstudo em Animais
  70. 1984

    Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse

    InconclusivoEstudo em Animais
  71. 1984

    Synthesis and pharmacological activity of some 9-substituted .DELTA.8-tetrahydrocannabinol (THC) analogs

    FavorávelEstudo em AnimaisDorTetraidrocanabinol (THC)
  72. 1976

    Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat

    InconclusivoEstudo em Animais
  73. 1973

    Comparative Studies in Man and in Laboratory Animals on ▵8- and ▵9-trans-Tetrahydrocannabinol

    InconclusivoEstudo em AnimaisTetraidrocanabinol (THC)
  74. 1973

    Delta-8- and delta-9-tetrahydrocannabinol; Comparison in man by oral and intravenous administration

    InconclusivoMetanáliseTetraidrocanabinol (THC)
  75. 1971

    Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse

    InconclusivoEstudo em AnimaisTetraidrocanabinol (THC)
  76. 1942

    Marihuana

    InconclusivoEnsaio ClínicoEfeitos Adversos da Cannabis

Continue por aqui

Perguntas frequentes

Quantos estudos sobre delta-8-thc estão indexados no acervo?
São 76 estudos, publicados entre 1942 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 29 · Estudo Laboratorial: 19 · Estudo em Animais: 17 · Ensaio Clínico: 6 · Ensaio Clínico Duplo-Cego: 3 · Metanálise Clínica: 2. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 33 favoráveis, 34 inconclusivos e 9 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Delta-8-THC — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/canabinoide/delta-8-thc/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Delta-8-THC — estudos científicos sobre cannabis. https://cannabisindica.com.br/canabinoide/delta-8-thc/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.